Quality of Sleep and Related Factors in Individuals Undergoing Methadone Maintenance Treatment

Document Type : Original Article

Authors

Department of Psychiatry, Shahid Beheshti Hospital, Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran

10.34172/ahj.1548

Abstract

Background: Poor sleep quality and its relationship with other sleep disorders and medical and psychiatric disorders have been noted in many individuals who use methadone as a maintenance treatment for drug abuse. This study aimed to investigate the quality of sleep and its related factors in people undergoing methadone maintenance treatment.
Methods: This study was conducted on 80 individuals who were undergoing methadone maintenance treatment (MMT) in MMT clinics selected by the convenience sampling method. The researcher-made data collection form, the Pittsburgh Sleep Quality Index questionnaire, and the Depression, Anxiety, and Stress Scale questionnaire were completed by the participants. Kendall’s tau-b correlation coefficient, chi-square, Mann-Whitney U, or Kruskal-Wallis tests were used for analyses.
Findings: In the present study, 80 participants undergoing maintenance treatment (86.25% male) were studied. Most individuals (75%) had good sleep quality (average questionnaire score of 4.31). In addition, the majority of participants had anxiety (63.75%; average score of 6.2), depression (66.25%; average score of 7.45), and stress at a normal level (91.25%; average score of 6.25). Women had significantly lower sleep quality than men (P = 0.009). The level of education (P = 0.036) and the frequency of alcohol consumption influenced sleep quality (P = 0.018). However, marital status, employment status, smoking, methamphetamine use, or use of drugs other than methadone were not significantly associated with sleep quality. The average score of sleep quality was significantly influenced by the level of anxiety (P < 0.001), depression (P < 0.001), and stress (P = 0.008). The age of starting methadone had a weak negative but significant correlation with the sleep quality score (τ = -0.2 and P = 0.01). The daily methadone dose had a weak but significant positive correlation with poorer sleep quality. (τ = 0.173 and P = 0.049).
Conclusion: Considering the significant relationship found between the severity of anxiety, depression, and stress and the quality of sleep in the participants of this study, it is recommended to screen these disorders more carefully in this group of people so that the necessary interventions can be carried out to improve their conditions. In addition, patients should be warned about consuming alcohol and increasing the daily dose of methadone.

Highlights

Farzaneh Jahanbakhsh(Google Scholar)(Pubmed)

Keywords

References

  1. Kaye AD, Jones MR, Kaye AM, Ripoll JG, Galan V, Beakley BD, et al. Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse: part 1. Pain Physician. 2017;20(2S):S93- 109.
  2. Degenhardt L, Grebely J, Stone J, Hickman M, Vickerman P, Marshall BD, et al. Global patterns of opioid use and dependence: harms to populations, interventions, and future action. Lancet. 2019;394(10208):1560-79. doi: 10.1016/ s0140-6736(19)32229-9.
  3. Soroosh D, Neamatshahi M, Zarmehri B, Nakhaee S, Mehrpour O. Drug-induced prolonged corrected QT interval in patients with methadone and opium overdose. Subst Abuse Treat Prev Policy. 2019;14(1):8. doi: 10.1186/s13011-019-0196-3.
  4. Eskandarieh S, Jafari F, Yazdani S, Hazrati N, Saberi- Zafarghandi MB. Compulsory maintenance treatment program amongst Iranian injection drug users and its side effects. Int J High Risk Behav Addict. 2014;3(4):e21765. doi: 10.5812/ ijhrba.21765.
  5. Bashardoost N, Tirani M. Prevalence of addiction in males: Isfahan 2003. ARYA Atheroscler. 2010;1(2):106-8.
  6. Azadfard M, Huecker MR, Leaming JM. Opioid addiction (archived). In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2025. Available from: https://pubmed. ncbi.nlm.nih.gov/28846246/.
  7. Dole VP, Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction. a clinical trial with methadone hydrochloride. JAMA. 1965;193:646-50. doi: 10.1001/jama.1965.03090080008002.
  8. Kanate D, Folk D, Cirone S, Gordon J, Kirlew M, Veale T, et al. Community-wide measures of wellness in a remote First Nations community experiencing opioid dependence: evaluating outpatient buprenorphine-naloxone substitution therapy in the context of a First Nations healing program. Can Fam Physician. 2015;61(2):160-5.
  9. Srivastava A, Kahan M, Nader M. Primary care management of opioid use disorders: abstinence, methadone, or buprenorphine-naloxone? Can Fam Physician. 2017;63(3):200-5.
  10. Centre for Addiction and Mental Health (CAMH). Opioid Agonist Therapy: A Synthesis of Canadian Guidelines: for Treating Opioid Use Disorder. Toronto: CAMH; 2021.
  11. Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2013 National Survey on Drug Use and Health: Mental Health Findings, NSDUH Series H-49. Rockville, MD: SAMHSA; 2014.
  12. Gisev N, Bharat C, Larney S, Dobbins T, Weatherburn D, Hickman M, et al. The effect of entry and retention in opioid agonist treatment on contact with the criminal justice system among opioid-dependent people: a retrospective cohort study. Lancet Public Health. 2019;4(7):e334-42. doi: 10.1016/ s2468-2667(19)30060-x.
  13. Morin KA, Eibl JK, Caswell JM, Gauthier G, Rush B, Mushquash C, et al. Concurrent psychiatry for patients enrolled in opioid agonist treatment: a propensity score matched cohort study in Ontario Canada. Subst Abuse Treat Prev Policy. 2019;14(1):29. doi: 10.1186/s13011-019-0213-6.
  14. Jones NR, Shanahan M, Dobbins T, Degenhardt L, Montebello M, Gisev N, et al. Reductions in emergency department presentations associated with opioid agonist treatment vary by geographic location: a retrospective study in New South Wales, Australia. Drug Alcohol Rev. 2019;38(6):690-8. doi: 10.1111/dar.12976.
  15. Hsu WY, Chiu NY, Liu JT, Wang CH, Chang TG, Liao YC, et al. Sleep quality in heroin addicts under methadone maintenance treatment. Acta Neuropsychiatr. 2012;24(6):356-60. doi: 10.1111/j.1601-5215.2011.00628.x.
  16. Peles E, Schreiber S, Hamburger RB, Adelson M. No change of sleep after 6 and 12 months of methadone maintenance treatment. J Addict Med. 2011;5(2):141-7. doi: 10.1097/ ADM.0b013e3181e8b6c4.
  17. Sharkey KM, Kurth ME, Anderson BJ, Corso RP, Millman RP, Stein MD. Obstructive sleep apnea is more common than central sleep apnea in methadone maintenance patients with subjective sleep complaints. Drug Alcohol Depend. 2010;108(1-2):77-83. doi: 10.1016/j. drugalcdep.2009.11.019.
  18. Baldassarri SR, Beitel M, Zinchuk A, Redeker NS, Oberleitner DE, Oberleitner LMS, et al. Correlates of sleep quality and excessive daytime sleepiness in people with opioid use disorder receiving methadone treatment. Sleep Breath. 2020;24(4):1729-37. doi: 10.1007/s11325-020-02123-z.
  19. Le TA, Dang AD, Tran AH, Nguyen LH, Nguyen TH, Phan HT, et al. Factors associated with sleep disorders among methadone-maintained drug users in Vietnam. Int J Environ Res Public Health. 2019;16(22):4315. doi: 10.3390/ ijerph16224315.
  20. Li DJ, Chung KS, Wu HC, Hsu CY, Yen CF. Predictors of sleep disturbance in heroin users receiving methadone maintenance therapy: a naturalistic study in Taiwan. Neuropsychiatr Dis Treat. 2018;14:2853-9. doi: 10.2147/ndt.S177370.
  21. Kakouei H, Zare S, Akhlagi AA, Panahi D. Evaluation of sleep quality in bus drivers in Tehran. Traffic Management Studies. 2010;5(16):1-10. [Persian].
  22. Samani S, Jokar B. Validity and reliability short-form version of the depression, anxiety and stress. J Soc Sci Humanit. 2007;26(3):65-77. [Persian].
  23. Ellis JD, Mayo JL, Gamaldo CE, Finan PH, Huhn AS. Worsening sleep quality across the lifespan and persistent sleep disturbances in persons with opioid use disorder. J Clin Sleep Med. 2022;18(2):587-95. doi: 10.5664/jcsm.9676.
  24. Liao Y, Tang J, Liu T, Chen X, Luo T, Hao W. Sleeping problems among Chinese heroin-dependent individuals. Am J Drug Alcohol Abuse. 2011;37(3):179-83. doi: 10.3109/00952990.2010.535580.
  25. Peles E, Schreiber S, Adelson M. Variables associated with perceived sleep disorders in methadone maintenance treatment (MMT) patients. Drug Alcohol Depend. 2006;82(2):103-10. doi: 10.1016/j.drugalcdep.2005.08.011.
  26. Peles E, Schreiber S, Adelson M. Documented poor sleep among methadone-maintained patients is associated with chronic pain and benzodiazepine abuse, but not with methadone dose. Eur Neuropsychopharmacol. 2009;19(8):581-8. doi: 10.1016/j.euroneuro.2009.04.001.
  27. Liao Y, Xie L, Chen X, Kelly BC, Qi C, Pan C, et al. Sleep quality in cigarette smokers and nonsmokers: findings from the general population in central China. BMC Public Health. 2019;19(1):808. doi: 10.1186/s12889-019-6929-4.
  28. Celik M, Cosentino D, Fuehrlein B. Sleep-wake disorders in veterans with opioid use disorder: Prevalence and comorbidities. Sleep Health. 2023;9(6):889-92. doi: 10.1016/j.sleh.2023.05.012.
  29. McLean CP, Asnaani A, Litz BT, Hofmann SG. Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness. J Psychiatr Res. 2011;45(8):1027-35. doi: 10.1016/j.jpsychires.2011.03.006.
  30. Qin A, Hu F, Qin W, Dong Y, Li M, Xu L. Educational degree differences in the association between work stress and depression among Chinese healthcare workers: Job satisfaction and sleep quality as the mediators. Front Public Health. 2023;11:1138380. doi: 10.3389/fpubh.2023.1138380.
  31. Nowakowska-Domagała K, Podlecka M, Stecz P, Lewandowska A, Sipowicz K, Kosmalski M, et al. The relationship between selected factors (temperament, bipolar traits, sleep quality, severity of addiction) and depressive symptoms in alcohol-dependent men. Int J Environ Res Public Health. 2023;20(5):4072. doi: 10.3390/ijerph20054072.
  32. Miyata S, Noda A, Ito N, Atarashi M, Yasuma F, Morita S, et al. REM sleep is impaired by a small amount of alcohol in young women sensitive to alcohol. Intern Med. 2004;43(8):679-84. doi: 10.2169/internalmedicine.43.679.
  33. Hernandez E, Griggs S. Sleep health among adults in outpatient opioid use disorder treatment: a systematic review. J Psychosoc Nurs Ment Health Serv. 2024;62(1):19-26. doi: 10.3928/02793695-20230622-04.
  34. Chen RW, Ulsa MC, Li P, Gao C, Zheng X, Xu J, et al. Sleep behavior traits and associations with opioid-related adverse events: a cohort study. Sleep. 2023;46(9):zsad118. doi: 10.1093/sleep/zsad118.
  35. Yoon JE, Oh D, Hwang I, Park JA, Im HJ, Thomas RJ, et al. Association between older subjective age and poor sleep quality: a population-based study. Behav Sleep Med. 2023;21(5):585-600. doi: 10.1080/15402002.2022.2144860.
  36. Kang SG, Bae SM. The effect of cigarette use and dual-use on depression and sleep quality. Subst Use Misuse. 2021;56(12):1869-73. doi: 10.1080/10826084.2021.1958855.
  37. Mathews HL, Stitzel JA. The effects of oral nicotine administration and abstinence on sleep in male C57BL/6J mice. Psychopharmacology (Berl). 2019;236(4):1335-47. doi: 10.1007/s00213-018-5139-6.
  38. Sun A, Wu X. Efficacy of non-pharmacological interventions on improving sleep quality in depressed patients: a systematic review and network meta-analysis. J Psychosom Res. 2023;172:111435. doi: 10.1016/j.jpsychores.2023.111435.
  39. Karimi R, Mallah N, Scherer R, Rodríguez-Cano R, Takkouche B. Sleep quality as a mediator of the relation between depression and chronic pain: a systematic review and meta-analysis. Br J Anaesth. 2023;130(6):747-62. doi: 10.1016/j. bja.2023.02.036.
  40. Hassamal S, Miotto K, Wang T, Saxon AJ. A narrative review: the effects of opioids on sleep disordered breathing in chronic pain patients and methadone maintained patients. Am J Addict. 2016;25(6):452-65. doi: 10.1111/ajad.12424.
  41. Theriot J, Sabir S, Azadfard M. Opioid antagonists. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2025.
Addiction & Health
Volume 17
Pages 1-7

Files

Share

How to cite

Statistics